Congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency

Endocrinologist

Volumn 13, Issue 4, 2003, Pages 334-340

  Speiser, Phyllis W ^a   Brenner, Dennis ^b  

^a SCHNEIDER CHILDREN'S HOSPITAL   (United States)

^b BAYSTATE MEDICAL CENTER   (United States)

Author keywords

Adrenal hyperplasia; Congenital; Hormones; Newborn screening; Prenatal diagnosis; Prenatal treatment; Steroid 21 hydroxylase; Steroid 21 monooxygenase

Indexed keywords

DEXAMETHASONE; FLUDROCORTISONE; GLUCOCORTICOID; HYDROCORTISONE; HYDROCORTISONE SODIUM SUCCINATE; MINERALOCORTICOID; PREDNISONE; SEX HORMONE; STEROID 21 MONOOXYGENASE; TETRACOSACTIDE;

CLINICAL FEATURE; CONGENITAL ADRENAL HYPERPLASIA; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG MEGADOSE; EDEMA; EPIDEMIOLOGICAL DATA; GROWTH RETARDATION; HETEROZYGOSITY; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HORMONE SYNTHESIS; HUMAN; HYPERTENSION; MOLECULAR GENETICS; NEWBORN SCREENING; PATHOPHYSIOLOGY; PERINATAL PERIOD; PRENATAL DIAGNOSIS; PREVALENCE; REPRODUCTION; REVIEW; SALT LOSING NEPHRITIS; SIDE EFFECT; STEROID 21 MONOOXYGENASE DEFICIENCY; SURGICAL TECHNIQUE; TACHYCARDIA; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 0043127278     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ten.0000088382.49099.0d     Document Type: Review

References (23)

1. Consensus Statement on 21-Hydroxylase Deficiency From the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society. Horm Res 2002;58:188-195.
2. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev. 2000;21:245-291.
3. White PC, Grossberger D, Onufer BJ, et al. Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man. Proc Natl Acad Sci USA. 1985;82:1089-1093.
4. Dupont B, Oberfield SE, Smithwick EM, et al. Close genetic linkage between HLA and congenital adrenal hyperplasia. Lancet. 1977;2:1309-1311.
5. Pollack MS, Maurer D, Levine LS, et al. HLA typing of amniotic cells: the prenatal diagnosis of congenital adrenal hyperplasia (21-OH-deficiency type). Transplant Proc. 1979;11:1726-1728.
6. Jaaskelainen J, Levo A, Voutilainen R, et al. Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well defined population. J Clin Endocrinol Metab. 1997;82:3293-3297.
7. Wedell A, Thilen A, Ritzen EM, et al. Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. J Clin Endocrinol Metab. 1994;78:1145-1152.
8. Wilson RC, Mercado AB, Cheng KC, et al. Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J Clin Endocrinol Metab. 1995;80:2322-2329.
9. Tajima T, Fujieda K, Nakae J, et al. Mutations of the CYP21 gene in nonclassical steroid 21-hydroxylase deficiency in Japan. Endocr J. 1998;45:493-497.
10. Weintrob N, Brautbar C, Pertzelan A, et al. Genotype-phenotype associations in non-classical steroid 21-hydroxylase deficiency. Eur J Endocrinol. 2000;143:397-403.
11. Prader A. Der genitalbefund beim pseudohermaphroditismus femininus der kengenitalen adrenogenitalen syndroms. Helv Paediatr Acta. 1954;9:231-248.
12. Forest MG, David M. Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a 10 year experience. Indian J Pediatr. 1992;59:515-52.
13. New MI, Carlson A, Obeid J, et al. Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J Clin Endocrinol Metab. 2001;86:5651-5657.
14. Clayton PE, Miller WL, Oberfield SE, et al. Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Pediatric Endocrinology. J Clin Endocrinol Metab. 2002;87:4048-4053.
15. Eugster EA, Dimeglio LA, Wright JC, et al. Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: a meta-analysis. J Pediatr. 2001;138:26-32.
16. Klingensmith GJ, Garcia SC, Jones HW, et al. Glucocorticoid treatment of girls with congenital adrenal hyperplasia: effects on height, sexual maturation, and fertility. J Pediatr. 1977;90:996-1004.
17. Helleday J, Siwers B, Ritzen EM, et al. Subnormal androgen and elevated progesterone levels in women treated for congenital virilizing 21-hydroxylase deficiency. J Clin Endocrinol Metab. 1993;76:933-936.
18. Speiser PW, Serrat J, New MI, et al. Insulin insensitivity in adrenal hyperplasia due to nonclassical steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab. 1992;75:1421-1424.
19. Merke DP, Fields JD, Keil MF, et al. Children with classic congenital adrenal hyperplasia have decreased amygdala volume: potential prenatal and postnatal hormone effects. J Clin Endocrinol Metab. 2003;88:1760-1765.
20. Dittmann RW, Kappes ME, Kappes MH. Sexual behavior in adolescent and adult females with congenital adrenal hyperplasia. Psychoneuroendocrinology. 1992;17:153-170.
21. Therrell BL Jr, Berenbaum SA, Manter-Kapanke V, et al. Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics. 1998;101:583-590.
22. Merke DP, Chrousos GP, Eisenhofer G, et al. Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency. N Engl J Med. 2000;343:1362-1368.
23. Meyer-Bahlburg HF. Gender and sexuality in classic congenital adrenal hyperplasia. Endocrinology & Metabolism Clinics of North America 2001;30:155-171.